FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00383565 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

NIH

Sponsor class

Conditions

Recurrent Adult Diffuse Large Cell Lymphoma
Recurrent Mantle Cell Lymphoma

Interventions

DRUG: romidepsin

Sponsor

National Cancer Institute (NCI)